Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201209068 Principal Investigator: Vij, Ravi
Title: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase: I Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to learn more about the investigational drug SAR650984 and when the study drug SAR650984 is given together with the drugs lenalidomide and dexamethasone.

We will evaluate the safety and the tolerability of the study drug and we will identify the maximum safe dose of SAR650984 when given together with lenalidomide and dexamethason.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)